Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-029162
Filing Date
2024-12-12
Accepted
2024-12-12 17:41:24
Documents
1
Period of Report
2024-12-10

Document Format Files

Seq Description Document Type Size
1 form4-12122024_101220.html 4  
1 form4-12122024_101220.xml 4 7202
  Complete submission text file 0001415889-24-029162.txt   8759
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Issuer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address
Chakma Justin (Reporting) CIK: 0001951238 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 241546153